In a surprising turnaround, Biogen Inc. announced Tuesday it would seek approval for an experimental Alzheimer’s treatment from the Food and Drug Administration.

Hope remains for fighting Alzheimer’s disease by removing amyloid plaques!

in News, Research Updates
October 23rd, 2019

In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer’s drug

Click HERE to learn more.